Skip Navigation
Skip to contents

ACC : Acute and Critical Care

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
7 "platelet"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Neurosurgery
A low preoperative platelet-to-white blood cell ratio is associated with acute kidney injury following cerebral aneurysm treatment in South Korea
Seung-Woon Lim, Woo-Young Jo, Hee-Pyoung Park
Acute Crit Care. 2025;40(1):59-68.   Published online February 21, 2025
DOI: https://doi.org/10.4266/acc.003120
  • 2,900 View
  • 140 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary Material
Background
Inflammation is involved in the pathophysiology of postoperative acute kidney injury (AKI). We investigated whether preoperative platelet-to-white blood cell ratio (PWR), a novel serum biomarker of systemic inflammation, was associated with postoperative AKI following cerebral aneurysm treatment. We also compared the discrimination power of preoperative PWR with those of other preoperative systemic inflammatory indices in predicting postoperative AKI.
Methods
Perioperative data including preoperative systemic inflammatory indices and cerebral aneurysm-related variables were retrospectively analyzed in 4,429 cerebral aneurysm patients undergoing surgical clipping or endovascular coiling. Based on the cutoff value of preoperative PWR, patients were divided into the high PWR (≥39.04, n=1,924) and low PWR (<39.04, n=2,505) groups. After propensity score matching (PSM), 1,168 patients in each group were included in the data analysis. AKI was defined according to the Kidney Disease Improving Global Outcomes guidelines.
Results
Postoperative AKI occurred more frequently in the low PWR group than in the high PWR group before PSM (45 [1.8%] vs. 7 [0.4%], P<0.001) and after (17 [1.5%] vs. 5 [0.4%], P=0.016). A low preoperative PWR was predictive of postoperative AKI before PSM (odds ratio [95% CI], 3.93 [1.74–8.87]; P<0.001) and after (3.44 [1.26–9.34], P=0.016). Preoperative PWR showed the highest area under the curve for postoperative AKI (0.713 [0.644–0.782], P<0.001), followed by preoperative platelet-to-neutrophil ratio (0.694 [0.619–0.769], P<0.001), neutrophil percentage-to-albumin ratio (0.671 [0.592–0.750], P<0.001), white blood cell-to-hemoglobin ratio (0.665 [0.579–0.750], P<0.001), neutrophil-to-lymphocyte ratio (0.648 [0.569–0.728], P<0.001), and systemic inflammatory index (0.615 [0.532–0.698], P=0.004).
Conclusions
A low preoperative PWR was associated with postoperative AKI following cerebral aneurysm treatment.

Citations

Citations to this article as recorded by  
  • Association between the platelet to white blood cell ratio and short term mortality in critically ill patients with atherosclerotic cardiovascular disease: A retrospective study and machine learning with external validation
    Zhantao Cao, Hewei Qin, Yue Niu, Zilu Zhang, Guoju Dong
    International Journal of Medical Informatics.2026; 209: 106267.     CrossRef
  • Platelet-to-white blood cell ratio as a predictor of postoperative outcomes in acute type A aortic dissection: a single-center retrospective analysis
    Biwen Yang, Yucheng Hou, Mingzhu Xu, Tingbo Jiang
    Frontiers in Cardiovascular Medicine.2026;[Epub]     CrossRef
  • A machine learning predictive model for acute kidney injury among aneurysmal subarachnoid hemorrhage patients
    Ruoran Wang, Lingzhu Qian, Yunhui Zeng, Linrui Cai, Min He, Jianguo Xu, Yu Zhang
    BMC Medical Informatics and Decision Making.2025;[Epub]     CrossRef
Trauma
Role of platelet-to-lymphocyte ratio at the time of arrival to the emergency room as a predictor of short-term mortality in trauma patients with severe trauma team activation
Jae Kwang Kim, Kyung Hoon Sun
Acute Crit Care. 2024;39(1):146-154.   Published online February 15, 2024
DOI: https://doi.org/10.4266/acc.2023.01319
  • 10,780 View
  • 291 Download
  • 5 Web of Science
  • 8 Crossref
AbstractAbstract PDF
Background
Platelet-to-Lymphocyte ratio (PLR) has been studied as a prognostic factor for various diseases and traumas. This study examined the utility of PLR as a tool for predicting 30-day mortality in patients experiencing severe trauma.
Methods
This study included 139 patients who experienced trauma and fulfilled ≥1 criteria for activation of the hospital’s severe trauma team. Patients were divided into non-survivor and survivor groups. Mean PLR values were compared between the groups, the optimal PLR cut-off value was determined, and mortality and survival analyses were performed. Statistical analyses were performed using SPSS ver. 26.0. The threshold of statistical significance was P<0.05.
Results
There was a significant difference in mean (±standard deviation) PLR between the non-survivor (n=36) and survivor (n=103) groups (53.4±30.1 vs. 89.9±53.3, respectively; P<0.001). Receiver operating characteristic (ROC) curve analysis revealed an optimal PLR cut-off of 65.35 (sensitivity, 0.621; specificity, 0.694, respectively; area under the ROC curve, 0.742), and Kaplan-Meier survival analysis revealed a significant difference in mortality rate between the two groups.
Conclusions
PLR can be calculated quickly and easily from a routine complete blood count, which is often performed in the emergency department for individuals who experience trauma. The PLR is useful for predicting 30-day mortality in trauma patients with severe trauma team activation.

Citations

Citations to this article as recorded by  
  • Key laboratory changes in severe trauma, a different pattern for each clinical phenotype
    Adrián Marcos-Morales, Jesús Abelardo Barea Mendoza, Marcos Valiente Fernández, Carlos García Fuentes, Fernando Calvo Boyero, Cecilia Cueto-Felgueroso, Judith Gutiérrez Gutiérrez, Francisco de Paula Delgado Moya, Carolina Mudarra Reche, Susana Bermejo Azn
    Medicina Intensiva (English Edition).2026; 50(4): 502227.     CrossRef
  • Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Combined with Model for End-Stage Liver Disease 3.0 as a Prognostic Predictor for Patients with Liver Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Creation
    Takeshi Suzuki, Kenkichi Michimoto, Kentaro Yamada, Khashayar Farsad
    Journal of Vascular and Interventional Radiology.2026; 37(2): 107922.     CrossRef
  • Stabilized C-reactive protein–albumin–lymphocyte (CALLY) index predicts adjacent fractures after kyphoplasty
    Chunbiao Deng, Haiqiao Huang, Linlin Chen, Xin Chen, Qian Chen, Yougang Liao, Shuliang Li
    BMC Musculoskeletal Disorders.2026;[Epub]     CrossRef
  • Key laboratory changes in severe trauma, a different pattern for each clinical phenotype
    Adrián Marcos-Morales, Jesús Abelardo Barea Mendoza, Marcos Valiente Fernández, Carlos García Fuentes, Fernando Calvo Boyero, Cecilia Cueto-Felgueroso, Judith Gutiérrez Gutiérrez, Francisco de Paula Delgado Moya, Carolina Mudarra Reche, Susana Bermejo Azn
    Medicina Intensiva.2026; 50(4): 502227.     CrossRef
  • Utility of platelet- to lymphocyte ratio as an inflammatory biomarker in major burns. our experience
    Dayamí Zaldívar Castillo MD, Néstor Nemer Pérez MD, Carlos Lora Buelvas MD, Adelmo de J González Méndez MD, Freddy J Cruz Reyes MD, Yaqueline Castellanos MD
    Journal of Anesthesia & Critical Care: Open Access.2025; 17(1): 1.     CrossRef
  • The predictors of prognostic nutritional index and its association with in-hospital mortality among critically ill geriatric patients
    Khalid Elsayed Elsorady, Ahmed Ahmed Mohamed Abotaha, Mohammed Abdelmoaty Ebrahim Shaheen, Hisham Ahmed Hani Mostafa Abdelaziz, Essam Yehia Ali Aggour, Mohamed Elwan Mohamed Mahmoud
    Electronic Journal of General Medicine.2025; 22(4): em656.     CrossRef
  • Prognostic Value of Inflammatory and Metabolic Biomarkers in ICU-Admitted Trauma Patients: A Retrospective Cohort Study
    Hasan Celik, Basak Pehlivan, Veli Fahri Pehlivan, Erdogan Duran
    Medicina.2025; 61(9): 1530.     CrossRef
  • Utility of systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio as a predictive biomarker in pediatric traumatic brain injury
    Muhammad Arifin Parenrengi, Wihasto Suryaningtyas, Ahmad Data Dariansyah, Budi Utomo, Glenn Otto Taryana, Catur Kusumo, Surya Pratama Brilliantika
    Surgical Neurology International.2024; 15: 456.     CrossRef
Review Article
Infection
Oxygen therapy for sepsis and prevention of complications
Hayk Minasyan
Acute Crit Care. 2022;37(2):137-150.   Published online March 17, 2022
DOI: https://doi.org/10.4266/acc.2021.01200
  • 22,784 View
  • 644 Download
  • 11 Web of Science
  • 12 Crossref
AbstractAbstract PDF
Patients with sepsis have a wide range of respiratory disorders that can be treated with oxygen therapy. Experimental data in animal sepsis models show that oxygen therapy significantly increases survival, while clinical data on the use of different oxygen therapy protocols are ambiguous. Oxygen therapy, especially hyperbaric oxygenation, in patients with sepsis can aggravate existing oxidative stress and contribute to the development of disseminated intravascular coagulation. The purpose of this article is to compare experimental and clinical data on oxygen therapy in animals and humans, to discuss factors that can influence the results of oxygen therapy for sepsis treatment in humans, and to provide some recommendations for reducing oxidative stress and preventing disseminated intravascular coagulation during oxygen therapy.

Citations

Citations to this article as recorded by  
  • Completion of the 1-Hour Sepsis Bundle on 90-Day Mortality in Adult Patients With Sepsis
    Suraphan Charoentanyarak, Thanapong Chopetgool, Watchara Boonsawat, Kittisak Sawanyawisuth
    JACEP Open.2026; 7(1): 100296.     CrossRef
  • Conservative Oxygen Targets in Mechanically Ventilated Patients (OXY-BREATHES): A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Nhan Nguyen, Nghi Bao Tran, Nathalia Alves de Barros e Lyra, Yacin Zawam, David Downes, Vinh Quang Tri Ho, Vy Ngoc Dan Nguyen, Ha Duc Thien Le, Jafar Aljazeeri
    Critical Care Medicine.2026;[Epub]     CrossRef
  • OPTIMAL PAO2 IS 130-160 MMHG IN THE FIRST WEEK FOR SEPSIS PATIENTS IN ICU: A RETROSPECTIVE COHORT STUDY BASED ON MIMIC-IV DATABASE
    Haoran Chen, Xinyi Tang, Xiaomin Li, Yongpeng Xie
    Shock.2025; 63(5): 688.     CrossRef
  • Postoperative pulmonary complications in acute type A aortic dissection
    Pengfei Chen, Haochao Li, Chenyu Liu, Mingjian Chen, Diming Zhao, Liang Chen, Xiangyang Qian, Jundong Pu, Zujun Chen, Yuetang Wang, Liqing Wang
    BMC Surgery.2025;[Epub]     CrossRef
  • Unraveling mitochondrial pyruvate dysfunction to mitigate hyperlactatemia and lethality in sepsis
    Louise Nuyttens, Marah Heyerick, Geike Heremans, Elise Moens, Maxime Roes, Céline Van Dender, Liesbet De Bus, Johan Decruyenaere, Jan Dewaele, Jolien Vandewalle, Claude Libert
    Cell Reports.2025; 44(8): 116032.     CrossRef
  • Monkeypox in neonates: A narrative review on clinical presentations, vertical transmission, and treatment challenges
    Ezza Ikram, Abaidullah Shaukat, Muhammad Shoaib Qureshi, Muneeb Saifullah, M Afaq Aslam, Abbas Muhammad Mehdi
    World Journal of Clinical Infectious Diseases.2025;[Epub]     CrossRef
  • Sequential respiratory support in septic patients undergoing continuous renal replacement therapy: A study based on MIMIC-III database
    Chunxia Wang, Jianli Zheng, Yilin Zhao, Tiantian Liu, Yucai Zhang
    Heliyon.2024; 10(6): e27563.     CrossRef
  • Hyperbaric Oxygenation: Can It Be a Novel Supportive Method in Acute Kidney Injury? Data Obtained from Experimental Studies
    Sanjin Kovacevic, Nikola Mitovic, Predrag Brkic, Milan Ivanov, Maja Zivotic, Zoran Miloradovic, Jelena Nesovic Ostojic
    Cells.2024; 13(13): 1119.     CrossRef
  • Hyperoxia in Sepsis and Septic Shock: A Comprehensive Review of Clinical Evidence and Therapeutic Implications
    Sharayu Paunikar, Vivek Chakole
    Cureus.2024;[Epub]     CrossRef
  • Personalized medicine targeting different ARDS phenotypes: The future of pharmacotherapy for ARDS?
    Florian Blanchard, Arthur James, Mona Assefi, Natacha Kapandji, Jean-Michel Constantin
    Expert Review of Respiratory Medicine.2023; 17(1): 41.     CrossRef
  • Current data regarding homeostasis of tissues oxygenation in pathophysiological and therapeutic circumstances
    Constantin Munteanu, Mihaela Antonina Călin, Dragoș Manea, Cristina Popescu, Mădălina Iliescu, Elena Valentina Ionescu, Liliana Stanciu, Mihaela Minea, Carmen Oprea, Doinița Oprea, Mariana Rotariu, Gelu Onose
    Balneo and PRM Research Journal.2023; 14(Vol.14, no): 565.     CrossRef
  • Current data regarding homeostasis of tissues oxygenation in pathophysiological and therapeutic circumstances
    Constantin Munteanu, Mihaela Antonina Călin, Dragoș Manea, Cristina Popescu, Mădălina Iliescu, Elena Valentina Ionescu, Liliana Stanciu, Mihaela Minea, Carmen Oprea, Doinița Oprea, Mariana Rotariu, Gelu Onose
    Balneo and PRM Research Journal.2023; 14(Vol.14, no): 565.     CrossRef
Case Report
Cardiology
ST-Segment Elevation Myocardial Infarction as a Result of Coronary Artery Ectasia-Related Intracoronary Thrombus in a Patient with Liver Cirrhosis
Ji Woong Roh, Eun Hyea Park, Joon Cheol Song, Young Seung Oh, Tong Yoon Kim, Hyo Suk Kim, Sungmin Lim
Korean J Crit Care Med. 2015;30(4):358-364.   Published online November 30, 2015
DOI: https://doi.org/10.4266/kjccm.2015.30.4.358
  • 7,870 View
  • 101 Download
  • 1 Crossref
AbstractAbstract PDF
Coronary artery ectasia (CAE) is a rare condition defined as the dilatation of coronary artery to at least 1.5 times larger than the normal adjacent coronary artery. Clinical manifestations of CAE vary, ranging from asymptomatic to ST-segment elevation myocardial infarction (STEMI). Because of its rarity and clinical diversity, the best treatment strategy and prognosis for CAE remain unclear. We describe a case of STEMI caused by intracoronary thrombus formation within an ectatic area in a patient with liver cirrhosis (LC). The patient was successfully managed by thrombus aspiration only, without balloon angioplasty or stent implantation, and maintained by dual antiplatelet therapy with aspirin and ticagrelor, a potent new P2Y12 inhibitor.

Citations

Citations to this article as recorded by  
  • Evaluation of body-mass index in patients with coronary artery ectasia
    Tolga Memioğlu, Mehmet İnanır, Murat Dıramalı, Salih Vahit Kiriş, İbrahim Güven, Kıvanç Argana, Kenan Toprak, Mehmet Özyaşar
    Anatolian Current Medical Journal.2025; 7(4): 404.     CrossRef
Original Articles
Pulmonary
Percutaneous Dilatational Tracheostomy in Critically Ill Patients Taking Antiplatelet Agents
Sung Jin Nam, Ji Young Park, Hongyeul Lee, Taehoon Lee, Yeon Joo Lee, Jong Sun Park, Ho Il Yoon, Jae Ho Lee, Choon Taek Lee, Young Jae Cho
Korean J Crit Care Med. 2014;29(3):183-188.   Published online August 31, 2014
DOI: https://doi.org/10.4266/kjccm.2014.29.3.183
  • 8,643 View
  • 94 Download
  • 5 Crossref
AbstractAbstract PDF
BACKGROUND
Percutaneous dilatational tracheostomy (PDT) has been considered as an alternative to surgical tracheostomy in intensive care units (ICU), and is widely used for critically ill patients who need prolonged mechanical ventilation. Few studies have reported on PDT performed in critically ill patients taking antiplatelet agents. Our goals are to assess not only the feasibility and safety of PDT, but also bleeding complications in the patients receiving such therapy.
METHODS
In a single institution, PDTs were performed by pulmonologists at the medical ICU bedside using the single tapered dilator technique and assisted by flexible bronchoscopy to confirm a secure puncture site. From March 2011 to February 2013, the patients' demographic and clinical data, procedural parameters, outcomes and complications were analyzed and compared complications between patients taking antiplatelet agents and those not.
RESULTS
PDTs were performed for 138 patients; the median age was 72 years, mean body mass index was 20.3 +/- 4.8 kg/m2, and mean acute physiology and chronic health evaluation II score was 24.4 +/- 9.4. Overall, the procedural success rate was 100% and the total procedural time was 25 +/- 8.5 min. There were no periprocedural life-threatening complications, and no statistical difference in the incidence of bleeding complications between patients who had taken antiplatelet agents and those had not (p = 0.657).
CONCLUSIONS
PDT performed in critically ill patients taking antiplatelet agents was a feasible procedure and was implemented without additional bleeding complications.

Citations

Citations to this article as recorded by  
  • Evaluation of the Safety of Percutaneous Dilatational Tracheostomies in Patients with Antiplatelet Therapy—A Comparison of Two Single-Step Percutaneous Dilatational Techniques
    Lukas Ley, Mustafa Kerem Cinar, Anita Windhorst, Jens Allendoerfer, Hossein Ardeschir Ghofrani, Dirk Bandorski
    Journal of Clinical Medicine.2025; 14(14): 5036.     CrossRef
  • Open tracheostomy in patients with dual platelet aggregation inhibitors
    Lorena Zapata-Contreras, Carlos Eduardo Hoyos-Cuervo, María Cristina Florián-Pérez
    Colombian Journal of Anesthesiology.2019; 47(3): 189.     CrossRef
  • Safety of Percutaneous Dilatational Tracheotomy in Patients on Dual Antiplatelet Therapy and Anticoagulation
    Enzo Lüsebrink, Konstantin Stark, Mattis Bertlich, Danny Kupka, Christopher Stremmel, Clemens Scherer, Thomas J. Stocker, Mathias Orban, Tobias Petzold, Nikolaus Kneidinger, Hans-Joachim Stemmler, Steffen Massberg, Martin Orban
    Critical Care Explorations.2019; 1(10): e0050.     CrossRef
  • Safety and Feasibility of Percutaneous Dilatational Tracheostomy in the Neurocritical Care Unit
    Dong Hyun Lee, Jin-Heon Jeong
    Journal of Neurocritical Care.2018; 11(1): 32.     CrossRef
  • Comparison of outcomes between vertical and transverse skin incisions in percutaneous tracheostomy for critically ill patients: a retrospective cohort study
    Sung Yoon Lim, Won Gun Kwack, Youlim Kim, Yeon Joo Lee, Jong Sun Park, Ho Il Yoon, Jae Ho Lee, Choon-Taek Lee, Young-Jae Cho
    Critical Care.2018;[Epub]     CrossRef
Usefulness of Thrombocytopenia and Changes in Platelet Counts as Prognostic Markers in Pediatric Intensive Care Units
Yoon Hee Kim, Hyun Bin Park, Min Jung Kim, Hwan Soo Kim, Hee Seon Lee, Yoon Ki Han, Kyung Won Kim, Myung Hyun Sohn, Kyu Earn Kim
Korean J Crit Care Med. 2013;28(2):93-100.
DOI: https://doi.org/10.4266/kjccm.2013.28.2.93
  • 3,700 View
  • 56 Download
AbstractAbstract PDF
BACKGROUND
Thrombocytopenia has been shown to be a useful predictor of mortality in adult intensive care units (ICUs). The aim of this study is to assess whether the level of platelet count at ICU admission and the changes in platelet counts can predict mortality in the pediatric ICU (PICU).
METHODS
Platelet counts were checked daily for at least 4 days in a total of 303 children who were admitted to the ICU. We compared the initial platelet counts and changes in platelet counts between survivors and non-survivors. A multivariable logistic regression model, a receiver operating characteristic curve and a linear mixed model were used.
RESULTS
The initial platelet count was significantly lower in non-survivors when compared to survivors. Multivariate analysis demonstrated that platelet count <120 x 10(9)/L (Odds ratio, 4.913; 95% confidence interval 2.451-9.851; p < 0.0001) was an independent predictor of mortality. In the case of children with thrombocytopenia (<120 x 10(9)/L) at admission to the ICU, the platelet counts increased serially in survivors, whereas non-survivors maintained their decreased platelet counts. In the case of children without thrombocytopenia, the platelet counts decreased most on day 3 in non-survivors.
CONCLUSIONS
At admission to the ICU, thrombocytopenia defined as a platelet count <120 x 10(9)/L can be a useful predictor of mortality in children. In children who had initial thrombocytopenia, the serial increase of platelet counts can be related to increased survival, whereas in children who did not have initial thrombocytopenia, more than a 10% decrease of platelet counts on day 3 can be related to mortality.
Case Report
Inhospital Spontaneous Acute Subdural Hematoma (SADH) Patient with Antiplatelet Therapy due to Acute Cerebral Ischemia: A Case Report
Hyo Chang Kim, Chun Sik Choi, Jae Young Yang, Hyun Chul Shin, Yu Sam Won, Young Jun Kwon
Korean J Crit Care Med. 2011;26(2):94-97.
DOI: https://doi.org/10.4266/kjccm.2011.26.2.94
  • 3,126 View
  • 20 Download
AbstractAbstract PDF
A case of "spontaneous" acute subdural hematoma caused by aspirin and plavix therapy has not been described previously. As an isolated cerebrovascular event related to aspirin and plavix therapy, this is the first report described in the literature. It also represents a new differential diagnosis for nontraumatic acute subdural hematomas.

ACC : Acute and Critical Care
TOP